RxDoctor Payments Data

Mitzi Gardner, APRN

Family · Powderly, KYNPI 1245481811

Payments from drug & device makers

$1,452in general payments, 2019–2025

Across 85 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$373
  • AbbVie$223
  • Pfizer$119
  • Lilly USA, LLC$100
  • Amgen$99
  • Bayer$98
  • plus $440 from 13 others

What the payments were for

  • Food & beverage$1,38695%
  • Education$665%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,452 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,417
Medicare patients
30
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$70,524
OzempicSemaglutide68$69,533
JanuviaSitagliptin Phosphate48$42,733
Repatha SureclickEvolocumab25$22,397
FarxigaDapagliflozin Propanediol29$20,728
EliquisApixaban24$16,842
LinzessLinaclotide29$16,241
JanumetSitagliptin Phos/Metformin Hcl23$15,195
KerendiaFinerenone11$13,286
Breo ElliptaFluticasone/Vilanterol11$8,405
Aripiprazole37$4,485
SymbicortBudesonide/Formoterol Fumarate14$3,557
Dexlansoprazole DrDexlansoprazole12$2,357
VascepaIcosapent Ethyl11$2,243
Trazodone Hcl118$2,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$373$69,53368 claims
AstraZenecaFarxiga, Symbicort$32$24,28543 claims
AbbVieLinzess, Synthroid$223$16,88841 claims
PfizerEliquis$119$16,84224 claims
BayerKerendia$98$13,28611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Powderly

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →